These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 1354657)

  • 1. Comparative review of third-generation progestins.
    Kafrissen ME; Corson SL
    Int J Fertil; 1992; 37 Suppl 2():104-15. PubMed ID: 1354657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Desogestrel, norgestimate, and gestodene: the newer progestins.
    Kaplan B
    Ann Pharmacother; 1995; 29(7-8):736-42. PubMed ID: 8520092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic profile of six oral contraceptives containing norgestimate, gestodene, and desogestrel.
    Teichmann A
    Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():98-104. PubMed ID: 8574257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of a new generation of oral contraceptives. The Advisory Board for the New Progestins.
    Speroff L; DeCherney A
    Obstet Gynecol; 1993 Jun; 81(6):1034-47. PubMed ID: 8497347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Third generation progestagens].
    Belaisch J; Eliakim V
    Contracept Fertil Sex (Paris); 1993 Apr; 21(4):287-93. PubMed ID: 12318226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative evaluation of the androgenicity of four low-dose, fixed-combination oral contraceptives.
    Coenen CM; Thomas CM; Borm GF; Rolland R
    Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():92-7. PubMed ID: 8574256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Side effects of third generation progestagens].
    Sitruk-ware R
    Contracept Fertil Sex (Paris); 1993 Apr; 21(4):295-300. PubMed ID: 12318229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Metabolic impact of current estrogen-progestins and cardiovascular consequences].
    Gaspard U; Lambotte R
    Bull Mem Acad R Med Belg; 1991; 146(8-10):334-42; discussion 342-5. PubMed ID: 1815814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The new pills: awaiting the next generation of oral contraceptives.
    Klitsch M
    Fam Plann Perspect; 1992; 24(5):226-8. PubMed ID: 1426186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic aspects of the new low-dose oral contraceptives.
    Chez RA
    Int J Fertil; 1989 Sep; 34 Suppl():50-4. PubMed ID: 2576259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term profile of a new progestin.
    Lippman J
    Int J Fertil; 1992; 37 Suppl 4():218-22. PubMed ID: 1362189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Disadvantages of third generation progestins].
    Sitruk-ware R
    Contracept Fertil Sex (Paris); 1993 Apr; 21(4):295-300. PubMed ID: 12318228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. European Society of Contraception oral contraceptives survey update: birth control methods in "Europe of the 12".
    Serfaty D; Wildemeersch D; Verougstraete A; Creatsas G
    Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():73-9. PubMed ID: 8574253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The latest progestagens].
    Belaisch J; Eliakim V
    Contracept Fertil Sex (Paris); 1993 Apr; 21(4):287-93. PubMed ID: 12318227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of nonfatal venous thromboembolism with oral contraceptives containing norgestimate or desogestrel compared with oral contraceptives containing levonorgestrel.
    Jick SS; Kaye JA; Russmann S; Jick H
    Contraception; 2006 Jun; 73(6):566-70. PubMed ID: 16730485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rationale for new oral contraceptive dosing.
    Williams JK
    Int J Fertil Womens Med; 2004; 49(1):30-5. PubMed ID: 15038507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [New progestational hormones].
    Köhler G; Göretzlehner G
    Zentralbl Gynakol; 1988; 110(13):801-8. PubMed ID: 2972141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of the androgenicity of progestins in hormonal therapy in women.
    Linn ES
    Clin Ther; 1990; 12(5):447-55. PubMed ID: 2268868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Influence of progestins on adverse effects of oral contraceptives].
    Wynn V
    Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):425-30. PubMed ID: 12280210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Oral contraception: advantages of estrogen reduction].
    Cohen J
    Contracept Fertil Sex (Paris); 1993 Jun; 21(6):489-94. PubMed ID: 12318239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.